Neurology Minute
1,957 episodes — Page 9 of 40
IGLON5 Frequency in Idiopathic REM Sleep Behavior Disorder - Part 2
In part two of this two-part series, Dr. Jeff Ratliff and Dr. Ron Postuma discuss how clinicians should approach serological antibody testing in patients with REM behavior disorder or other associated neurologic symptoms. Show reference: https://www.neurology.org/doi/10.1212/NXI.0000000000200311
IGLON5 Frequency in Idiopathic REM Sleep Behavior Disorder - Part 1
In part one of this two-part series, Dr. Jeff Ratliff and Dr. Ron Postuma discuss how frequently the IGLON5 antibody is identified among patients with idiopathic REM behavior disorder. Show reference: https://www.neurology.org/doi/10.1212/NXI.0000000000200311
Artificial Intelligence in Residency Recruitment - Part 1
In part one of this two-part series, Dr. Jeff Ratliff and Drs. Rachel Gottlieb-Smith and Kathryn Xixis discuss the potential advantages that the increasing accessibility of artificial intelligence presents for the identification and recruitment of the next generation of neurologists. Show reference: https://www.neurology.org/doi/10.1212/NE9.0000000000200150
EEG Education in Child Neurology and Neurodevelopmental Disabilities Residencies - Part 3
In the third part of this three-part series, Dr. Irfan Sheikh and Dr. Roohi Katyal discuss the best strategies to enhance EEG education in child neurology and neurodevelopmental disability programs. Show reference: https://www.neurology.org/doi/10.1212/NE9.0000000000200112
EEG Education in Child Neurology and Neurodevelopmental Disabilities Residencies - Part 2
In the second part of this three-part series, Dr. Irfan Sheikh and Dr. Roohi Katyal discuss the current state of EEG education in child neurology and neurodevelopmental disability programs, focusing on EEG rotation characteristics and resident evaluations. Show reference: https://www.neurology.org/doi/10.1212/NE9.0000000000200112
EEG Education in Child Neurology and Neurodevelopmental Disabilities Residencies - Part 1
In the first part of this three-part series, Dr. Irfan Sheikh and Dr. Roohi Katyal discuss the significance of this publication and the objectives their team aimed to achieve with the study. Show reference: https://www.neurology.org/doi/10.1212/NE9.0000000000200112
Central Mechanisms of Cough and Their Neurologic Implications
Dr. Derek Stitt and Dr. Reece Hass discuss the neuroanatomy of the cough reflex, the relationship between cough and pain, and specific neurological conditions that can lead to neurogenic cough. Show reference: https://www.neurology.org/doi/10.1212/WNL.0000000000210064
Medical Forecasting - Part 2
In the second part of this two-part series, Dr. Justin Abbatemarco and Drs. Claire J. Creutzfeldt and Robert G. Holloway discuss how medical forecasting can assist in answering questions that patients or family members often ask. Show reference: https://jamanetwork.com/journals/jamaneurology/article-abstract/2820194
Medical Forecasting - Part 1
In part one of this two-part series, Dr. Justin Abbatemarco and Drs. Claire J. Creutzfeldt and Robert G. Holloway discuss understanding medical forecasting. Show reference: https://jamanetwork.com/journals/jamaneurology/article-abstract/2820194
Understanding Amyloidosis
In this episode of Neurology Minute, Dr. Stacey Clardy discusses Amyloidosis. Show reference: https://doi.org/10.1111/imj.15974
Uncertainties Regarding Cerebral Palsy Diagnosis - Part 2
In the second part of this two-part series, Dr. Stacey Clardy and Dr. Bhooma R. Aravamuthan talk about the future of the diagnostic label for cerebral palsy. Show reference: https://www.neurology.org/doi/10.1212/CPJ.0000000000200353
Distinguishing Prodromal Dementia with Lewy Bodies from Prodromal Alzheimer Disease
Dr. Vikram Karnik and Dr. Kate Wyman-Chick discuss distinguishing prodromal dementia with Lewy bodies from prodromal Alzheimer disease and the implications for clinical practice. Show reference: https://www.neurology.org/doi/10.1212/CPJ.0000000000200380
Uncertainties Regarding Cerebral Palsy Diagnosis - Part 1
In the first part of this two-part series, Dr. Stacey Clardy and Dr. Bhooma R. Aravamuthan discuss the current definition of cerebral palsy and the appropriate diagnostic labeling in clinical practice. Show reference: https://www.neurology.org/doi/10.1212/CPJ.0000000000200353
CMS Releases Final 2025 Physician Fee Schedule - Part 3
In part three of this three-part series, Dr. Jason Crowell and Max Goldman discuss potential legislative actions affecting the 2025 Medicare Physician Fee Schedule. Show references: Fee for Service Page Webinar sign up link Full Physician Fee Schedule Final Rule
CMS Releases Final 2025 Physician Fee Schedule - Part 2
In part two of this three-part series, Dr. Jason Crowell and Matt Kerschner explores advancements and challenges in telehealth services for 2025. Show references: Fee for Service Page Webinar sign up link Full Physician Fee Schedule Final Rule
CMS Releases Final 2025 Physician Fee Schedule - Part 1
In part one of this three-part series, Dr. Jason Crowell and Matt Kerschner discuss the key updates and changes to the Medicare Physician Fee Schedule for 2025. Show references: Fee for Service Page Webinar sign up link Full Physician Fee Schedule Final Rule
Understanding Acute Symptomatic Seizures
Dr. Halley Alexander and Dr. Vineet Punia discuss factors influencing the decision to continue or discontinue anti-seizure medications at discharge for patients hospitalized with acute symptomatic seizures. Show reference: https://jamanetwork.com/journals/jamaneurology/article-abstract/2824063
Features of Educational Social Media Posts - Part 2
In the second episode of this two-part series, Dr. Stacey Clardy and Dr. Catherine Albin discuss the differences between traditional educational methods and the innovative use of social media for teaching. Show references: https://www.neurology.org/doi/10.1212/NE9.0000000000200160
Features of Educational Social Media Posts - Part 1
In the first episode of this two-part series, Dr. Stacey Clardy and Dr, Catherine Albin discuss the key features of educational social media posts that drive high sharing and engagement. Show references: https://www.neurology.org/doi/10.1212/NE9.0000000000200160
Hereditary Ataxia SCA27B
Dr. Vikram Karnak discusses the novel hereditary ataxia SCA27b, its genetic basis, symptoms, and potential treatments, emphasizing the need for testing in unexplained adult-onset ataxia.
Long-Term Outcomes and Rehabilitation in Anti-NMDAR Encephalitis - Part 2
In part two of this two-part series, Dr. Justin Abbatemarco and Dr. Maarten Titulaer discuss the link between HSV and NMDAR encephalitis and how that impacts longitudinal recovery. Show reference: https://www.neurology.org/doi/pdf/10.1212/WNL.0000000000210109
Long-Term Outcomes and Rehabilitation in Anti-NMDAR Encephalitis - Part 2
In part two of this two-part series, Dr. Justin Abbatemarco and Dr. Maarten Titulaer discuss the link between HSV and NMDAR encephalitis and how that impacts longitudinal recovery. Show reference: https://www.neurology.org/doi/pdf/10.1212/WNL.0000000000210109
Long-Term Outcomes and Rehabilitation in Anti-NMDAR Encephalitis - Part 1
In part one of this two-part series, Dr. Justin Abbatemarco and Dr. Maarten Titulaer discuss long-term cognitive and functional outcomes in patients with anti-NMDAR encephalitis and their implications for rehabilitation. Show reference: https://www.neurology.org/doi/pdf/10.1212/WNL.0000000000210109
Myelitis Associated With Rheumatologic Disease - Part 2
In part two of this two-part series, Dr. Stacey Clardy and Dr. Elias Sotirchos discuss abandoning the term lupus myelitis and emphasize the importance of accurately naming and identifying each autoimmune condition. Show reference: https://www.neurology.org/doi/10.1212/NXI.0000000000200329
Myelitis Associated With Rheumatologic Disease - Part 1
In part one of this two-part series, Dr. Stacey Clardy and Dr. Elias Sotirchos discuss key features of inflammatory myelopathy in rheumatologic disease, helping to better characterize the underlying causes of lupus myelitis. Show reference: https://www.neurology.org/doi/10.1212/NXI.0000000000200329
Could GLP-1 Receptor Agonists Reduce the Risk of Neurologic Disorders?
Dr. Tesha Monteith discusses the Brain & Life article, "Could GLP-1 Receptor Agonists Reduce the Risk of Neurologic Disorders?" by Hallie Levine, available in the latest issue of Brain & Life or at brainandlife.org. Show reference: https://www.brainandlife.org/articles/new-weight-loss-drugs-may-help-neurologic-disorders
CAA-RI and Biopsy-Positive Primary Angiitis of the CNS - Part 3
In the final part of this three-part series, Dr. Justin Abbatemarco and Dr. Ahmad Nehme discuss how to differentiate between CAA-RI and PACNS. Show reference: https://www.neurology.org/doi/abs/10.1212/WNL.0000000000209548
The Placebo Effect
Dr. Gregg Day and Dr. Kathryn T. Hall discuss the complexities of the placebo effect, its variability among patients, and the genetic factors that influence responses to placebo treatments.
CAA-RI and Biopsy-Positive Primary Angiitis of the CNS - Part 2
In part two of this three-part series, Dr. Justin Abbatemarco and Dr. Ahmad Nehme discuss the underlying pathophysiology and how to diagnose primary angiitis of the CNS in clinical practice. Show reference: https://www.neurology.org/doi/abs/10.1212/WNL.0000000000209548
CAA-RI and Biopsy-Positive Primary Angiitis of the CNS - Part 1
In part one of this three-part series, Dr. Justin Abbatemarco and Dr. Ahmad Nehme discuss how cerebral amyloid angiopathy and CAA-RI present in clinical practice and how to make a diagnosis. Show reference: https://www.neurology.org/doi/abs/10.1212/WNL.0000000000209548
Lab Minute - Vitamin D
Dr. Stacey Clardy discusses vitamin D in this lab minute.
Could Reducing Environmental Toxins Help Mitigate the Risk for Parkinson's Disease? Where the Evidence Is Leading
Dr. Halley Alexander discusses the Neurology Today article, "Could Reducing Environmental Toxins Help Mitigate the Risk for Parkinson's Disease? Where the Evidence Is Leading" by Gina Shaw, available in the November 7th issue of Neurology Today or at neurologytoday.com. Show reference: https://journals.lww.com/neurotodayonline/pages/articleviewer.aspx?year=2024&issue=11070&article=00001&type=Fulltext
Genetic Leukodystrophies Mimicking CNS Inflammation - Part 3
In the final part of this three-part series, Dr. Justin Abbatemarco and Dr. Jennifer L. Orthmann Murphy highlight important indicators for when to suspect hereditary spastic paraplegia, as well as guidelines for testing and interpreting results. Show references: https://www.neurology.org/doi/10.1212/NXG.0000000000200192 https://cshperspectives.cshlp.org/content/early/2024/08/10/cshperspect.a041457
Genetic Leukodystrophies Mimicking CNS Inflammation - Part 2
In part two of this three-part series, Dr. Justin Abbatemarco and Dr. Jennifer L. Orthmann Murphy discuss practical approaches to genetic adrenoleukodystrophy. Show references: https://www.neurology.org/doi/10.1212/NXG.0000000000200192
Genetic Leukodystrophies Mimicking CNS Inflammation - Part 1
In the first part of this three-part series, Dr. Justin Abbatemarco and Dr. Jennifer L. Orthmann Murphy discuss red flag symptoms that suggest the need for genetic testing in patients with white matter disease. Show references: https://www.neurology.org/doi/10.1212/NXG.0000000000200192 https://cshperspectives.cshlp.org/content/early/2024/08/10/cshperspect.a041457
Early Treatment Cuts Relapse Risk in Myelin Oligodendrocyte Glycoprotein Antibody-Associated Disease
Dr. Rae Bacharach discusses the Neurology Today article, "Early Treatment Cuts Relapse Risk in Myelin Oligodendrocyte Glycoprotein Antibody-Associated Disease," by Gina Shaw, available in the latest issue of Neurology Today or at neurologytoday.com. Show reference: https://journals.lww.com/neurotodayonline/pages/default.aspx https://jamanetwork.com/journals/jamaneurology/article-abstract/2822964
Interventions for the Acute Management of Migraine Episodes in Adults - Part 3
In the final part of this three-part series, Drs. Tesha Monteith, Messoud Ashina, and Andrea Cipriani discuss what you need to know about analyzing network meta-analysis. Show reference: https://www.bmj.com/content/386/bmj-2024-080107
Eculizumab Use in Neuromyelitis Optica Spectrum Disorders
Drs. Justin Abbatemarco, Marius Ringelstein, and Ilya Ayzenberg discuss a new class of complement inhibitors that we're using in NMOSD. Show reference: https://www.neurology.org/doi/full/10.1212/WNL.0000000000209888
Interventions for the Acute Management of Migraine Episodes in Adults - Part 2
In part two of this three-part series, Drs. Tesha Monteith, Messoud Ashina, and Andrea Cipriani discuss clinical pearls on how to select an acute treatment plan for migraine. Show reference: https://www.bmj.com/content/386/bmj-2024-080107
Interventions for the Acute Management of Migraine Episodes in Adults - Part 1
In the first part of this three-part series, Drs. Tesha Monteith, Messoud Ashina, and Andrea Cipriani explain the significance of this study and how its findings can be applied in clinical practice. Show reference: https://www.bmj.com/content/386/bmj-2024-080107
Timing of Anticoagulation Resumption and Risk of Ischemic and Hemorrhagic Complications in Patients With ICH and Mechanical Heart Valves
Dr. Jodie Roberts and Dr. Amra Sakusic discusses the relationship between reversal therapy and ischemic stroke, between duration off anticoagulation and risk of ischemic strokes or systemic embolism. Learn more about the Neurology Practice Current section and fill out the survey now. Show reference: https://survey.alchemer.com/s3/7969148/Practice-Current-When-do-you-start-anticoagulation-therapy-for-patients-with-both-ICH-and-AF https://www.neurology.org/doi/10.1212/WNL.0000000000209664
Women History Minute - The Women of the Cajal School
In this Women's History Minute, Dr. Alison Christy discusses the Cajal School of Neuropathology in Spain and emphasizes the importance of mentorship.
Revised Criteria for Diagnosis and Staging of Alzheimer Disease
Dr. Greg Cooper and Dr. Clifford R. Jack Jr. discuss objective criteria for diagnosis and staging Alzheimer disease, highlighting recent advancements in biomarkers to bridge the gap between research and clinical practice. Show reference: https://pubmed.ncbi.nlm.nih.gov/38934362/
End-of-Life Health Care Service Use and Cost
Dr. Gordon Smith and Dr. Whitley Aamodt discuss end-of-life care for patients with neurodegenerative diseases, focusing on healthcare utilization, hospice enrollment, and the importance of early conversations about care preferences. Show reference: https://www.neurology.org/doi/10.1212/WNL.0000000000209925
Women History Minute - Cecile Vogt
Dr. Alison Christy delves into another women's history minute to discuss Cecile Vogt.
Neurology on the Hill
Dr. Jason Crowell talks about Neurology on the Hill and how you can get involved if you are interested. Show reference: https://www.aan.com/policy-and-guidelines/capitol-hill-report/
A Comparison of Side Effects for Four First-line Antiseizure Medications
Dr. Halley Alexander discusses the Neurology Today article, "A Comparison of Side Effects for Four First-line Antiseizure Medications" by Stacey Burling, available in the September 19th issue of Neurology Today or at neurologytoday.com. Show reference: https://journals.lww.com/neurotodayonline/fulltext/2024/09190/a_comparison_of_side_effects_for_four_first_line.1.aspx
Epilepsy in Patients With Primary CNS Lymphoma
Dr. Kait Nevel and Dr. Oumaima Aboubakr discuss the prevalence of epilepsy in primary CNS lymphoma. Show reference: https://www.neurology.org/doi/abs/10.1212/WNL.0000000000209748
The Rise of the Science Sleuths - Part 3
In the final part of this three-part series, Drs. Stacey Clardy, Elisabeth Bik, and Matthew Schrag discuss how to uphold research integrity. Show reference: https://undark.org/2024/09/11/the-rise-of-the-science-sleuths/
Lab Minute - B Vitamins
Dr. Stacey Clardy discusses why B vitamins matter in neurology in this lab minute.